Home / Internal Medicine
Internal Medicine
| 5 min read
The life sciences sector contributes billions to the economy, but current policy and international factors are threatening growth.
| 5 min read
Pulmonary fibrosis patients have long suffered through side effects from their drugs. That could change with the potential for new inhaled versions in clinical trials.
| 2 min read
Qureight’s Vascul8 model uses AI to analyse CT scans and identify patients at risk of residual pulmonary hypertension after surgery.
| 4 min read
Scientists are using insights from viral hijacking to chemically reprogram E3 ligases, opening new opportunities in drug discovery.
| 3 min read
A team from Stanford and NYU shows how Bacteroides fragilis can activate pain pathways, revealing a new microbial culprit in digestive disease.
| 3 min read
A novel cannabis-based therapy shows promise as a safe, effective non-opioid alternative for chronic low back pain.
| 7 min read
Men have long lacked reversible contraceptives, but new hormonal and non-hormonal methods in development could finally give them control over family planning.
| 5 min read
Computational models are reshaping how therapies are discovered, tested, and optimized.
| 5 min read
Regulatory science is increasingly relying on modeling, simulation, and AI tools to accelerate drug development while maintaining safety and efficacy.
| 5 min read
Animal and cell culture models have fallen short in kidney disease research. Kidney organoids may offer a better way forward.
| 2 min read
A $500k award will support a two-phase study enrolling pregnant women to advance understanding of placental dysfunction.
